
Laura Ingraham @IngrahamAngle
*Though studies are still on, HCQ probably interferes with the glycosylation of ACE2 (the cellular receptor of SARS-CoV-2) and blocks viral fusion with the host cells....” Hydroxychloroquine in dermatology and beyond: Recent update. https://t.co/6GFsHesYqO — PolitiTweet.org